Nikolai Kley

Company: Orionis Biosciences

Job title: Founder & Chief Executive Officer

Seminars:

Reprogramming the Cancer Immunity Cycle With Cis-Acting Cytokines 9:00 am

Understanding the design and engineering of targeted, conditionally active cytokines Harnessing the therapeutic potential of interferons, interleukins and tumor necrosis factor(s) Reprogramming the tumor microenvironment: targeting immune cells and tumor cellsRead more

day: Scientific Day Two

Panel Discussion: Guiding Cytokines to Their Appropriate Target Using Novel Mechanisms to Maximize the Efficacy of the Drug- Panel Discussion 10:00 am

Developing technologies that are more selective Using antibody targeting technology to direct the cytokines Targeting the linker closest to the tumor to make the approach more specificRead more

day: Scientific Day Two